TipRanks
Go Ultimate55% OFF

Aktis Oncology, Inc. (AKTS) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
[225Ac]Ac-Aky-1189, [64Cu]Cu-Aky-1189Non Small Cell Lung Cancer, Head And Neck Cancer, Colorectal Adenocarcinoma, Triple Negative Breast Cancer (Tnbc), Cervical Adenocarcinoma, Urothelial Carcinoma Bladder, Hormone Receptor Positive Breast AdenocarcinomaPhase IRecruitingA Study of [225Ac]Ac-AKY-1189 in Patients With Solid TumorsMay 28, 2025―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Aktis Oncology, Inc. (AKTS) have in its pipeline
Aktis Oncology, Inc. AKTS is currently developing the following drugs: [225Ac]Ac-Aky-1189, [64Cu]Cu-Aky-1189. These drug candidates are in various stages of clinical development as the company works toward FDA approval.